Role of Ultrasound in Diagnosis of Muscle Diseases

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

April 4, 2024

Study Completion Date

July 1, 2024

Conditions
UltrasoundMuscle Disease
Interventions
DEVICE

Neuromuscular Ultrasound (US)

"Quantitative ultrasound measurements will be performed to studied muscles according to a standard protocol; for each muscle three consecutive measurements will be made to minimize variation in echo intensity during analysis .The captured images will be analyzed offline for echo intensity by means of computer-assisted grayscale histogram analysis.The study will be performed using My lab 7 ultrasound system (Esaote company, Italy) that is equipped by 7-19 MHz linear array transducer and color and power Doppler.~Technique: evaluation of studied muscles for echo intensity (ECHO), quantitative assessments of echointensity, muscle perfusion, transverse and longitudinal sections of the muscle and its thickness at rest and during maximal voluntary contractions (MVC), overlying subcutaneous fat, cross-sectional area (CSA), and angled fibers of pennate muscles."

DEVICE

Electrophysiological studies

"Includes: Motor and sensory nerve conduction study, F-wave and H-reflex study to assess the proximal roots, Electromyography (EMG) of the studied muscles.~using machine: recordings will be performed with a Nihon Kohden equipment (model 7102) with the following parameters: sweep time 8 ms/D, sensitivity 0.5 mV/D, low frequency filter 2 Hz, high frequency filter 10 kHz, stimulation duration 0.1 ms and stimulation frequency 1 Hz."

DIAGNOSTIC_TEST

Seum CPK, CK-MM levels, Lactate dehydrogenase and alanine aminotransferase.

measured in U/L using ELISA.

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04233255 - Role of Ultrasound in Diagnosis of Muscle Diseases | Biotech Hunter | Biotech Hunter